General form of registration statement for all companies including face-amount certificate companies

SHAREHOLDERS' EQUITY (Tables)

v3.23.3
SHAREHOLDERS' EQUITY (Tables)
6 Months Ended 12 Months Ended
Jun. 30, 2023
Dec. 31, 2022
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Schedule of stock options activity

Options Outstanding

    

    

Weighted

    

Weighted

    

Average

Average

Number of

Exercise

Remaining

Aggregate

Shares Subject

Price Per

Contractual

Intrinsic Value

to Options

Share

Life (in years)

(in thousands)

Balance at December 31, 2021

 

60,212

$

111.20

 

3.60

 

  

Options granted

 

6,500

$

103.20

Options exercised

 

(40)

$

100.80

Options canceled / expired

 

(17,632)

$

50.20

Balance at December 31, 2022

 

49,040

$

129.60

2.8

Options granted

 

10,000

$

0.86

Options canceled / expired

 

(11,670)

$

122.54

Balance at June 30, 2023

 

47,370

$

131.09

 

2.8

 

$

Vested and exercisable at June 30, 2023

 

32,733

$

134.36

 

2.2

 

$

Options Outstanding

    

    

Weighted

    

Weighted

    

Average

Average

Number of

Exercise

Remaining

Aggregate

Shares Subject

Price Per

Contractual

Intrinsic Value

to Options

Share

Life (in years)

(in thousands)

Balance at December 31, 2020

 

37,430

$

105.00

 

4.00

 

  

Options granted

 

27,250

$

123.40

Options exercised

 

(150)

$

128.00

Options canceled / expired

 

(4,318)

$

119.80

Balance at December 31, 2021

 

60,212

$

111.20

3.6

Options granted

 

6,500

$

103.20

Options exercised

 

(40)

$

100.80

Options canceled / expired

 

(17,632)

$

50.20

Balance at December 31, 2022

 

49,040

$

129.60

 

2.8

 

$

Vested and exercisable at December 31, 2022

 

34,163

$

135.20

 

2.4

 

$

Schedule of stock options outstanding and exercisable

Options Outstanding

Options Exercisable

    

Weighted

    

    

    

Average

Weighted

Weighted

Remaining

Average

Average

Number of

Contractual

Exercise Price

Number

Exercise Price

Outstanding

Life (in years)

Per Share

Exercisable

Per Share

750

 

4.6

$

180.00

 

750

$

180.00

3,400

 

0.3

$

180.00

 

3,400

$

180.00

5,740

 

0.5

$

156.00

 

5,740

$

156.00

3,025

 

1.3

$

128.00

 

3,025

$

128.00

3,250

 

2.4

$

97.00

 

2,383

$

97.00

11,205

2.6

$

106.00

8,550

$

106.00

1,500

2.8

$

112.00

1,100

$

112.00

7,000

3.3

$

153.00

5,085

$

153.00

1,500

3.7

$

103.20

700

$

103.20

10,000

5.0

$

0.86

2,000

$

0.86

47,370

 

2.8

$

131.09

 

32,733

$

134.36

Options Outstanding

Options Exercisable

    

Weighted

    

    

    

Average

Weighted

Weighted

Remaining

Average

Average

Number of

Contractual

Exercise Price

Number

Exercise Price

Outstanding

Life (in years)

Per Share

Exercisable

Per Share

750

 

5.0

$

180.00

 

750

$

180.00

4,200

 

0.8

$

180.00

 

4,200

$

180.00

7,290

 

1.0

$

156.00

 

7,290

$

156.00

3,695

 

1.8

$

128.00

 

3,695

$

128.00

4,150

 

2.9

$

97.00

 

3,043

$

97.00

12,655

3.1

$

106.00

7,520

$

106.00

1,500

3.3

$

112.00

900

$

112.00

8,300

3.8

$

153.00

4,598

$

153.00

6,500

4.2

$

103.20

2,167

$

103.20

49,040

 

2.8

$

129.60

 

34,163

$

135.20

Schedule of assumptions were used to determine fair value of the awards

    

Six Months Ended June 30, 

 

2023

    

2022

Expected life (in years)

 

5.0

 

5.0

Risk-free interest rate

 

4.0

%  

1.7

%

Dividend yield

 

%  

%

Expected volatility

 

137

%  

132

%

    

Year Ended December 31, 

 

2022

    

2021

Expected life (in years)

 

5.0

 

5.0

Risk-free interest rate

 

1.7

%  

0.4-0.9

%

Dividend yield

 

%  

%

Expected volatility

 

132

%  

91-137

%

Schedule of changes in stock option liability  

Changes in the Company’s stock option liability for the years ended December 31, 2022 and 2021 were as follows (stated in thousands):

Balance at December 31, 2020

    

$

16

Gain on revaluation

 

(9)

Balance at December 31, 2021

$

25

Gain on revaluation

 

25

Balance at December 31, 2022

$

Schedule of warrants

    

Number of Warrants outstanding

Balance at December 31, 2021

 

197,000

Debenture, warrants issued

9,000

Balance at December 31, 2022

 

206,000

Warrants expired

 

(11,026)

Balance at June 30, 2023

 

194,974

    

Number of Warrants outstanding

Convertible debt, warrants issued (Note 5)

 

8,645

Debenture, warrants issued (Note 5)

13,750

Other warrants issued

9,000

December 2020 equity financing warrants issued (1)

163,579

Total warrant outstanding

 

194,974

    

Number of Warrants outstanding

Balance at December 31, 2020

 

183,250

Debenture, warrants issued (Note 10)

13,750

Balance at December 31, 2021

 

197,000

Warrants issued

 

9,000

Balance at December 31, 2022

 

206,000

Schedule of warrants, valuation assumptions  

    

Year Ended

Year Ended

December 31, 2022

    

December 31, 2021

Risk free rate of return

0.56

%

0.39

%

Expected life

4.0

years  

5.0

years

Expected volatility

90

%

90

%

Expected dividend per share

nil

nil

Exercise price

$

1.51

$

0.78

Stock price

$

1.50

$

0.96

Consultants    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Schedule of assumptions were used to determine fair value of the awards  

As of December 31,

2021

Risk free rate of return

0.4

%

Expected life

0.8

years

Expected volatility

186

%

Expected dividend per share

nil